NeuroBo Pharmaceuticals | 4:持股變動聲明-高管 Woodworth Marshall H
NeuroBo Pharmaceuticals | 4:持股變動聲明-董事 Tursi James Patrick
NeuroBo Pharmaceuticals | 3:首次持股聲明-董事 Tursi James Patrick
NeuroBo Pharmaceuticals | 3:首次持股聲明-高管 Woodworth Marshall H
NeuroBo Pharmaceuticals | 4:持股變動聲明-高管 Kim Hyung Heon
NeuroBo Pharmaceuticals | 4:持股變動聲明-董事 KOVEN ANDREW I
NeuroBo Pharmaceuticals | 4:持股變動聲明-董事 Salsbury Michael
NeuroBo Pharmaceuticals | 4:持股變動聲明-董事 STRICKLAND D GORDON
NeuroBo Pharmaceuticals | 4:持股變動聲明-董事 GROVES JASON L
NeuroBo Pharmaceuticals | 4:持股變動聲明-董事 Glickman Mark A
NeuroBo Pharmaceuticals | 4:持股變動聲明-董事 Kim Na Yeon
NeuroBo Pharmaceuticals | 4/A:持股變動聲明(修正)-董事 Kim Na Yeon
NeuroBo Pharmaceuticals | 3:首次持股聲明-董事 Glickman Mark A
NeuroBo Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Strategic Risk, LLC.(6.3%)
NeuroBo Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Altium Growth Fund, LP(0%),Altium Capital Management, LP(0%)等
NeuroBo Pharmaceuticals | 3:首次持股聲明-高管 Hooker Joseph
NeuroBo Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-Dong-A ST Co., Ltd.(65.5%)
NeuroBo Pharmaceuticals | 3:首次持股聲明-股東 GOLDMAN SACHS GROUP INC
NeuroBo Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Altium Capital Management, LP EIN:(7.7%),Altium Growth Fund, LP EIN:(7.7%)等
NeuroBo Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-Dong-A ST Co., Ltd.(2.4%)
暫無數據